Onco Wiki / Maladie

Lymphome principal (thymique) du médiastin (B-Cell)

Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.

IDDIS-PMBCL
TypeMaladie
Alias
LBCL médiastinalPMBCLPMLBCLLymphome principal médiastinal Grand lymphome B-CellПервинна медіастинальна (тимічна) B-великоклітинна лімфома
Étatreviewed 2026-04-25 | pending_clinical_signoff
MaladiesAucune déclaration
SourcesSRC-NCCN-BCELL-2025

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Source YAML

icd_o_3_morphology9679/3
icd_10C85.2
who_classificationAggressive B-cell lymphomas — Primary mediastinal (thymic) large B-cell lymphoma per WHO 5th ed.

Capacités

Notes

STUB — pending Clinical Co-Lead approval per CHARTER §6.1. CT chest з biopsy of mediastinal mass — initial workup. Avoid steroids перед biopsy if possible. CNS prophylaxis not routine. Differential — anterior/superior mediastinal mass: sarcoidosis (D86.0–D86.2) can present identically to PMBCL on CT (bulky mediastinal mass, bilateral hilar nodes, pleural/pericardial effusions). PET/CT uptake indistinguishable. Biopsy essential; sarcoid granulomata (non-caseating, CD15−/CD30−, no malignant large B-cells) exclude PMBCL. ACE, serum calcium, BAL cell differential help pre-biopsy. Do not start R-CHOP / DA-EPOCH-R on imaging alone.

Utilisé par

Algorithmes

Maladie

Indication

Questionnaires

Signal d’alerte

Sources